---
title: "Long Beach Medical Center joins global trial of Corvia® Atrial Shunt for heart failure patients in 2026. #HFpEF #heartfailure"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/275655488.md"
description: "Long Beach Medical Center's MemorialCare Heart & Vascular Institute, situated in Long Beach, California, is among just two locations in the state taking part in the worldwide RESPONDER HF trial. This trial is focused on assessing the effectiveness of the Corvia® Atrial Shunt in individuals struggling with heart failure. The news was announced on February 11, 2026."
datetime: "2026-02-11T20:40:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275655488.md)
  - [en](https://longbridge.com/en/news/275655488.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275655488.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/275655488.md) | [English](https://longbridge.com/en/news/275655488.md)


# Long Beach Medical Center joins global trial of Corvia® Atrial Shunt for heart failure patients in 2026. #HFpEF #heartfailure

Long Beach Medical Center's MemorialCare Heart & Vascular Institute, situated in Long Beach, California, is among just two locations in the state taking part in the worldwide RESPONDER HF trial. This trial is focused on assessing the effectiveness of the Corvia® Atrial Shunt in individuals struggling with heart failure. The news was announced on February 11, 2026.

### 相關股票

- [China Universal CNI HK Connect Innovative Drugs Industry ETF (159570.CN)](https://longbridge.com/zh-HK/quote/159570.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-HK/quote/516930.CN.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-HK/quote/512010.CN.md)
- [Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880.CN)](https://longbridge.com/zh-HK/quote/520880.CN.md)
- [Bosera Hang Seng SCHK Innovative Drug Select ETF (520690.CN)](https://longbridge.com/zh-HK/quote/520690.CN.md)
- [ChinaAMC Hang Seng Biotechnology Technology ETF(QDII) (159892.CN)](https://longbridge.com/zh-HK/quote/159892.CN.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-HK/quote/159849.CN.md)
- [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-HK/quote/LABU.US.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-HK/quote/159837.CN.md)
- [E Fund Hang Seng SCHK Innovative Drug ETF (159316.CN)](https://longbridge.com/zh-HK/quote/159316.CN.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/zh-HK/quote/512290.CN.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/zh-HK/quote/588130.CN.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [Yinhua CSI Innovative Drugs Industry ETF (159992.CN)](https://longbridge.com/zh-HK/quote/159992.CN.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-HK/quote/510660.CN.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-HK/quote/516500.CN.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-HK/quote/IXJ.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [Proshares UltraShort Nasdaq Biotech (BIS.US)](https://longbridge.com/zh-HK/quote/BIS.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md)

## 相關資訊與研究

- [Merck & Co Inc Says Winrevair Meets Primary Endpoint In Phase 2 Cadence Trial](https://longbridge.com/zh-HK/news/280915405.md)
- [Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst⢠(bumetanide nasal spray)](https://longbridge.com/zh-HK/news/281570860.md)
- [Stocks in Play: Ventripoint Diagnostics Ltd](https://longbridge.com/zh-HK/news/281544776.md)
- [Bayer Announces Approval Of New Indication For Kerendia In The EU](https://longbridge.com/zh-HK/news/280969658.md)
- [FDA Approves Eli Lilly's Foundayo For Adults With Obesity, Weight-Related Medical Conditions](https://longbridge.com/zh-HK/news/281395378.md)